menu search

IMGO / Imago BioSciences: The Bone Marrow Cancer Researcher Reaches Milestone

Imago BioSciences: The Bone Marrow Cancer Researcher Reaches Milestone
Imago BioSciences becomes part of the Merck & Co., Inc. family for $1.35 billion. Imago BioSciences, Inc. will certainly strengthen Merck's position in hematology. Read More
Posted: Nov 30 2022, 16:07
Author Name: Seeking Alpha
Views: 111530

IMGO News  

Imago BioSciences: The Bone Marrow Cancer Researcher Reaches Milestone

By Seeking Alpha
November 30, 2022

Imago BioSciences: The Bone Marrow Cancer Researcher Reaches Milestone

Imago BioSciences becomes part of the Merck & Co., Inc. family for $1.35 billion. Imago BioSciences, Inc. will certainly strengthen Merck's position i more_horizontal

Imago (IMGO) Shares Surge 104% on Buyout Offer From Merck

By Zacks Investment Research
November 22, 2022

Imago (IMGO) Shares Surge 104% on Buyout Offer From Merck

Imago BioSciences (IMGO) to be acquired by pharma-giant Merck (MRK) for $1.35 billion. The transaction is likely to close by first-quarter 2023. more_horizontal

Why Earnings Season Could Be Great for Imago BioSciences (IMGO)

By Zacks Investment Research
February 28, 2022

Why Earnings Season Could Be Great for Imago BioSciences (IMGO)

Imago BioSciences (IMGO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season. more_horizontal

Why Earnings Season Could Be Great for Imago BioSciences (IMGO)

By Zacks Investment Research
February 28, 2022

Why Earnings Season Could Be Great for Imago BioSciences (IMGO)

Imago BioSciences (IMGO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season. more_horizontal

Why Earnings Season Could Be Great for Imago BioSciences (IMGO)

By Zacks Investment Research
February 28, 2022

Why Earnings Season Could Be Great for Imago BioSciences (IMGO)

Imago BioSciences (IMGO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season. more_horizontal


Search within

Pages Search Results: